Literature DB >> 24176291

Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.

C Greenaway1, J F Boivin2, S Cnossen2, C Rossi3, B Tapiero4, K Schwartzman5, S Olson6, M Miller1.   

Abstract

Varicella occurs at an older age in tropical compared to cold climates. Migrants from tropical countries provide the opportunity to gain insights into observed global differences in varicella epidemiology. Severity of varicella increases with age thus, description of risk factors for varicella susceptibility will identify those who would benefit most from vaccination. A total of 1480 migrants, with a mean age of 32 years, were recruited in the pre-vaccination period (2002-2004) in Montreal, Canada. A questionnaire was administered and serum varicella antibodies were measured. Overall 6% were susceptible and ranged from 0·8% to 14·1% in subgroups. Risk factors for susceptibility were younger age, recent arrival, and originating from a tropical country. This could be modified by conditions that increased the probability of person-to-person spread of varicella through direct contact in source countries such as larger community size or household crowding. Many new young adult migrants would benefit from targeted varicella vaccination programmes.

Entities:  

Mesh:

Year:  2013        PMID: 24176291      PMCID: PMC9151238          DOI: 10.1017/S0950268813002768

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  31 in total

1.  Economic evaluation of vaccination programs: the impact of herd-immunity.

Authors:  M Brisson; W J Edmunds
Journal:  Med Decis Making       Date:  2003 Jan-Feb       Impact factor: 2.583

2.  Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).

Authors:  M Juffrie; R R Graham; R I Tan; S Widjaja; S Mulyadi; J Weil; H L Bock
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-03       Impact factor: 0.267

3.  Immigration flows and new epidemiological evidence in southern Italy.

Authors:  Giovanni Gabutti; Alberto Fedele; Valerio Aprile; Marcello Guido; Pierluigi Lopalco
Journal:  Vaccine       Date:  2003-01-17       Impact factor: 3.641

4.  Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis.

Authors:  Patrick Merrett; Kevin Schwartzman; Paul Rivest; Christina Greenaway
Journal:  Clin Infect Dis       Date:  2007-03-13       Impact factor: 9.079

5.  Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?

Authors:  Jeffrey C Kwong; Peter Tanuseputro; Brandon Zagorski; Rahim Moineddin; Kevin J Chan
Journal:  Vaccine       Date:  2008-08-30       Impact factor: 3.641

6.  Varicella among adults: data from an active surveillance project, 1995-2005.

Authors:  Mona Marin; Tureka L Watson; Sandra S Chaves; Rachel Civen; Barbara M Watson; John X Zhang; Dana Perella; Laurene Mascola; Jane F Seward
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

7.  Decreasing rates of hospitalization for varicella among young adults.

Authors:  V E Herrin; G C Gray
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

8.  Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.

Authors:  Marc Brisson; Gurgen Melkonyan; Melanie Drolet; Gaston De Serres; Roseline Thibeault; Philippe De Wals
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

9.  Decline in mortality due to varicella after implementation of varicella vaccination in the United States.

Authors:  Huong Q Nguyen; Aisha O Jumaan; Jane F Seward
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

10.  The epidemiology of varicella and its complications.

Authors:  P W Choo; J G Donahue; J E Manson; R Platt
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

View more
  6 in total

1.  Risk Factors for Varicella Susceptibility Among Refugees to Toronto, Canada.

Authors:  Geneviève Cadieux; Vanessa Redditt; Daniela Graziano; Meb Rashid
Journal:  J Immigr Minor Health       Date:  2017-02

2.  Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases.

Authors:  Vanessa J Redditt; Praseedha Janakiram; Daniela Graziano; Meb Rashid
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

3.  Serological Susceptibility to Varicella Among U.S. Immigration and Customs Enforcement Detainees.

Authors:  Aiden K Varan; Edith R Lederman; Shanon S Stous; Diana Elson; Jennifer L Freiman; Mona Marin; Adriana S Lopez; William M Stauffer; Rachael H Joseph; Stephen H Waterman
Journal:  J Correct Health Care       Date:  2017-09-25

4.  Summary of the Statement on International Travellers Who Intend to Visit Friends and Relatives.

Authors:  J Brophy
Journal:  Can Commun Dis Rep       Date:  2015-05-07

5.  Epidemic Varicella Zoster Virus among University Students, India.

Authors:  Josh Meyers; Muthunarayanan Logaraj; Balaji Ramraj; Padmanesan Narasimhan; C Raina MacIntyre
Journal:  Emerg Infect Dis       Date:  2018-02       Impact factor: 6.883

6.  Vaccine completion and infectious diseases screening in a cohort of adult refugees following resettlement in the U.S.: 2013-2015.

Authors:  Amir M Mohareb; Bryan Brown; Kevin S Ikuta; Emily P Hyle; Aniyizhai Annamalai
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.